Newsfeeds Archive - Page 6 of 696

2 minute read

American Environmental Partners Signs Definitive Agreement For Reverse Merger With Nasdaq Listed SCWorx Corp.

December 26, 9:07 AM

American Environmental to List on Nasdaq Upon Closing Under Ticker Symbol: AEPT CANONSBURG, PA, Dec. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –American Environmental Partners, Inc.

AEPT

2 minute read

CVRx Receives FDA Approval For Expanded Labeling Of Barostim

By Happy Mohamed

December 26, 9:06 AM

CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has approved revised Instructions For Use (IFU) for Barostim

CVRX

1 minute read

News

Adit EdTech Acquisition Corp. Announces Intention To Voluntarily De-List From NYSE American

By Happy Mohamed

December 26, 9:05 AM

Adit EdTech Acquisition Corp. (NYSE:ADEX)(NYSE:ADEX)(NYSE:ADEX) ("ADEX" or the "Company"), a special purpose acquisition company, announced today that it intends to voluntarily de-list its common

ADEX

1 minute read

electroCore Expands Intellectual Property Portfolio; The Two Patents Were Issued On December 26, 2023, And Relate To ElectroCore’s Non-Invasive Vagus Nerve Stimulation Technology

By Happy Mohamed

December 26, 9:04 AM

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO).

ECOR

2 minute read

Daré Bioscience Secures $12M In Royalty-Backed Investment Structure; Daré Issued To The Investor A 5-Year Warrant To Purchase An Aggregate Of 5M Shares Of Daré’s Common Stock At An Exercise Price Of $0.3467 Per Share

By Happy Mohamed

December 26, 9:02 AM

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it has entered into a royalty-backed financing agreement that provides Daré with $5 million at

DARE

4 minute read

60 Degrees Pharma Announces IRB Approval Of Phase IIA Study To Evaluate Tafenoquine For Babesiosis, An Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled By FDA To January 17, 2024

By Happy Mohamed

December 26, 9:00 AM

Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma's double-blind, placebo-controlled study to investigate tafenoquine for treatment of hospitalized babesiosis

SXTP

2 minute read

Brown & Brown, Inc. Enters Into Agreement To Acquire Caton-Hosey Insurance; No Financial Terms Disclosed

By Happy Mohamed

December 26, 8:54 AM

J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Rex Caton and John Hosey, the owners of Caton-Hosey Insurance ("Caton Hosey"), today announced that Brown & Brown has

BRO

2 minute read

Legal
News

‘Apple To Pull Apple Watch Series 9 And Ultra 2 This Week Due To ITC Ban/ It All Revolves Around A Patent Battle With Medical Device Maker Masimo Over The SpO2 Sensor’ – TheVerge

By Happy Mohamed

December 18, 10:56 AM

https://www.theverge.com/2023/12/18/24006080/apple-watch-ban-series-9-ultra-2-itc-import

AAPL

3 minute read

‘Carl C. Icahn Issues Open Letter To Shareholders of Illumina, Inc.’

By Happy Mohamed

December 18, 10:47 AM

https://carlicahn.com/open-letter-to-shareholders-of-illumina-inc-13/ Dear Fellow Stockholders: Our campaign at Illumina has had three main goals. We accomplished the first goal with the removal of prior Chairman John

ILMN

2 minute read

Andelyn Biosciences Selected By Ultragenyx For Late-Stage Process Performance Qualification Manufacturing Of Novel Gene Therapy For Sanfilippo Syndrome

By Happy Mohamed

December 18, 10:38 AM

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ:RARE) to

RARE